Additionally, tumor-derived factors such as TGF-β, ATP, and indoleamine 2,3-dioxygenase (IDO) have been shown to reinforce the immunosuppressive function of Tregs within the TME (37–39). The gene discussed is TGFB1; the disease is neoplasm.